DRUGS recently approved around the world to fight cancer increased patients' overall survival, but benefits vary depending on the drug, a new study shows.
Researchers looked at the 62 cancer drugs approved in the U.S. and Europe between 2003 and 2013 and found they extended survival by an average of about 3.5 months.
But nearly a third of the drugs lacked evidence to suggest they increased survival when compared to alternative treatments.
"Our results point to the notion that new cancer treatments may not always provide patients with greater clinical benefits, or lower risks, over existing treatments," wrote senior researcher Dr. Elias Mossialos, of the London School of Economics and Political Science, in an email to Reuters Health.
The risk-benefit ratio of new drugs is especially important if people are concerned, for example, about whether the cost of a drug would make it difficult for a person to complete the treatment regimen.
Writing in JAMA Oncology, Mossialos and colleagues point to growing questions about the value of new cancer medicines. While the drugs' high costs may be a barrier to access, they note, some people argue the high prices are justified if the treatments offer large benefits.
A lack of solid data on new drugs' benefits and risks makes it difficult to evaluating their value.
For the 62 medicines they wanted to study, the researchers found data from England, France and Australia evaluating 53 drugs. Nearly 80 percent were tied to improvements in survival, quality of life or safety.
The drugs increased survival - with or without recurrence - by about 3.5 months on average, compared to other treatments available in 2003.
Twenty-three drugs were individually tied to an increase in survival of three months or more. Six drugs extended survival by less than three months. Eight drugs increased survival by an unknown amount. And for 16 of the approved drugs, there was no evidence to suggest they were better than alternative treatments at extending survival.
The researchers point out in an email that overall survival benefits differed by the type of drug. For example, drugs for thyroid cancer were tied to no increase in overall survival, while drugs to treat breast cancer were linked to an average increase of about 8.5 months.
Twenty-two of the drugs were tied to an improved quality of life, but 24 were linked to worse patient safety, which include side effects and whether a person could tolerate the treatment.
The researchers write in their email that they extending the study to look at newer drugs. They are also working to link their evidence with the cost of individual medicines.
Mossialos said the study should remind people of the importance of the relationship between doctors and patients. He said, "Patients should work with their physicians to consider all available evidence that exists in support of individual treatments, and use this alongside any inputs from their clinician to identify the treatment that would best correspond with their own medical and personal circumstances."
Reuters
Tue Jan 03 2017
The drugs increased survival - with or without recurrence - by about 3.5 months on average, compared to other treatments available in 2003. - Photo for illustration purpose only
AWANI 7:45 [28/04/2024] – Malaysia tumpu pelaburan baharu | Pertumbuhan saksama dan inklusif | Kajian pertubuhan buruh antarabangsa | Tabung Haji teruskan bantuan
Laporan berita padat dan ringkas #AWANI745 bersama Dzulfitri Yusof
Tumpuan #AWANI745 malam ini:
- Malaysia hadapi cabaran baharu dari negara maju, bidang teknologi, tegas PM
- Ekonomi dunia kian tidak seimbang, Tengku Zafrul di pentas forum desak negara maju lebih adil dan saksama
- 70 peratus pekerja dunia terdedah kepada penyakit akibat perubahan iklim
- Tabung Haji tanggung kos lebih RM350 juta tahun ini
Tumpuan #AWANI745 malam ini:
- Malaysia hadapi cabaran baharu dari negara maju, bidang teknologi, tegas PM
- Ekonomi dunia kian tidak seimbang, Tengku Zafrul di pentas forum desak negara maju lebih adil dan saksama
- 70 peratus pekerja dunia terdedah kepada penyakit akibat perubahan iklim
- Tabung Haji tanggung kos lebih RM350 juta tahun ini
Liek Hou rangkul dua lagi emas di Sepanyol
Jaguh badminton para negara Cheah Liek Hou terus cemerlang apabila menggondol dua pingat emas pada Kejohanan Badminton Para Sepanyol Antarabangsa II 2024 pada Sabtu.
Rakyat Malaysia di Jordan jadi duta produk PMKS negara - Ewon
Datuk Ewon Benedick menyarankan rakyat Malaysia yang menetap di Jordan supaya memainkan peranan sebagai "duta" untuk mempromosikan produk PMKS dan koperasi negara.
Fokus Minggu Depan: Solidariti Gaza Merentasi Bangsa dan Agama
Break The Siege: Fokus Minggu Depan membincangkan topik Solidariti Gaza Merentasi Bangsa dan Agama susulan penangguhan misi penghantaran bantuan ke Gaza anjuran Freedom Flotilla Coalition (FFC).
Lelaki rugi lebih RM13,000 terperdaya tawaran kerja dalam talian
Seorang lelaki berputih mata apabila wangnya berjumlah RM13,460 lesap setelah menjadi mangsa penipuan tawaran kerja.
Misi ditangguh, delegasi Malaysia berlepas pulang
Delegasi Malaysia dalam misi Break The Siege Freedom Flotilla To Gaza akan berlepas pulang malam ini.
Keputusan dicapai selepas Freedom Flotilla Coalition (FFC) tidak dapat meneruskan misi selepas Republik Guinea-Bissau menarik balik kebenaran menggunakan bendera untuk dua kapal yang digunakan.
Laporan lanjut bersama Syaff Shukri di Istanbul.
Keputusan dicapai selepas Freedom Flotilla Coalition (FFC) tidak dapat meneruskan misi selepas Republik Guinea-Bissau menarik balik kebenaran menggunakan bendera untuk dua kapal yang digunakan.
Laporan lanjut bersama Syaff Shukri di Istanbul.
Ustaz Wan sanggup bina tempat main boling DIY di sekolah kampung
Ustaz Wan mempunyai minat yang sangat tinggi terhadap sukan boling dan berhasrat untuk turut mengasah bakat anak muridnya.
Karnival Malaysia di New Delhi tarik 2,000 pengunjung
Pengunjung diraikan dengan persembahan kebudayaan, makanan, demonstrasi masakan, mencanting batik dan peluang merasai buah-buahan tropika Malaysia.
Anak-anak mula terima kenyataan ibu sudah tiada - Suami Nurfarahimi
"Sebagai ayah, saya menasihati mereka untuk menerima apa yang telah ditentukan Allah SWT."
Mahmoud Abbas menyeru semua negara iktiraf Palestin
Presiden Palestin Mahmoud Abbas menyeru semua negara untuk mengiktiraf Palestin sebagai negara merdeka serta mengiktiraf ahli penuh Persatuan Bangsa Bangsa Bersatu (PBB). Beliau diberi peluang berucap di Mesyuarat Khas Forum Ekonomi Dunia (WEF) di Arab Saudi hari ini.
Memerangi kanser payudara ketika pandemik COVID-19
Kebanyakan kanser payudara bermula dari sel yang melapisi bahagian saluran (ductal cancer), sebahagian lain bermula pada kelenjar lobul (lobular cancer) dan selebihnya bermula dari tisu-tisu lain.
Pesakit kanser cabar diri sendiri terima kad Krismas dari seluruh Amerika
Ternyata dengan kuasa media sosial, Ryan menerima 3000 kad daripada kesemua 50 negeri di Amerika Syarikat dan 29 negara.
Angelina Jolie umum buang ovari bimbang terjadi kanser
Angelina Jolie hari ini mengumumkan bahawa beliau telah menjalani pembedahan membuang ovari dan tiub fallopio dua tahun lepas.